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Abstract
RNA-directed DNA methylation (RdDM) and histone H3 lysine 9 dimethylation (H3K9me2) are related transcriptional
silencing mechanisms that target transposable elements (TEs) and repeats to maintain genome stability in plants. RdDM is
mediated by small and long noncoding RNAs produced by the plant-specific RNA polymerases Pol IV and Pol V, respectively.
Through a chemical genetics screen with a luciferase-based DNA methylation reporter, LUCL, we found that camptothecin, a
compound with anti-cancer properties that targets DNA topoisomerase 1a (TOP1a) was able to de-repress LUCL by reducing
its DNA methylation and H3K9me2 levels. Further studies with Arabidopsis top1a mutants showed that TOP1a silences
endogenous RdDM loci by facilitating the production of Pol V-dependent long non-coding RNAs, AGONAUTE4 recruitment
and H3K9me2 deposition at TEs and repeats. This study assigned a new role in epigenetic silencing to an enzyme that
affects DNA topology.
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Introduction
DNA methylation and histone H3 lysine 9 (H3K9) methylation
are two chromatin modifications widely employed by eukaryotes
to maintain genome stability [1,2]. H3K9 methylation and DNA
methylation are targeted via small interfering RNAs (siRNAs) to
repeats and transposable elements (TEs) and are required for their
transcriptional silencing [1,2].
In plants, cytosine methylation is established through a process
known as RNA-directed DNA methylation (RdDM), which
involves small and long noncoding RNAs produced by plant-
specific RNA polymerases, Pol IV and Pol V, respectively [2]. Pol
IV is thought to transcribe RdDM target loci and generate long
precursor RNAs. These are eventually processed into 24-nucle-
otide (nt) siRNAs that are loaded into the Argonaute protein
AGO4 [3,4,5,6,7]. In parallel, Pol V generates long non-coding
RNA transcripts from RdDM target loci, and these transcripts
recruit siRNA-AGO4 to chromatin [8,9]. Through the concerted
action of these two polymerases, siRNA-AGO4 becomes localized
to target loci, and this ultimately recruits the methyltransferase
DRM2, which effects de novo DNA methylation. In plants, DNA
methylation occurs in three sequence contexts, CG, CHG, and
CHH. In contrast to CG and CHG methylation, which can be
maintained through the DNA methyltransferases MET1 and
CMT3, respectively, CHH methylation is propagated by constant
de novo methylation through RdDM [2,10].
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In plants, H3K9 dimethylation (H3K9me2) is another repres-
sive chromatin mark associated with TE and repeat silencing
[11,12,13]. H3K9me2 and CHG methylation act in a self-
reinforcing loop to promote the maintenance of these marks by
histone methyltransferases KRYPTONITE (KYP or SUVH4),
SUVH5 and SUVH6 and the DNA methyltransferase CMT3
[14]. How H3K9me2 is initially deposited is less well understood,
but the RdDM pathway plays a role, as mutations in RdDM
pathway genes cause marked reductions in H3K9me2 levels at
RdDM target loci [7,8,15]. In fact, a recent study revealed a
strong genome-wide inter-dependence between non-CG (CHG
and CHH) DNA methylation and H3K9 dimethylation [16].
DNA topoisomerases are enzymes that maintain proper DNA
topology [17]. During replication or transcription, the DNA
helical structure opens to form the replication or transcription
fork, and the DNA in front of the fork becomes positively
supercoiled, while the DNA behind the fork becomes negatively
supercoiled. Topoisomerases bind these regions, nick the DNA to
relieve the torsional stress, and re-ligate the DNA. Topoisomerases
are divided into two major types, I and II, and further subtypes
depending on their mode of action and structure [17,18].
In Arabidopsis, there are two genes encoding type IB topoisom-
erases, TOP1a and TOP1b, which are tandemly arrayed in the
genome. top1a mutants exhibit gross morphological defects, while
top1b mutants are phenotypically normal [19]. RNAi-mediated
knockdown of TOP1b in a top1a background is lethal [19]; thus
these two genes are functionally redundant.
Here, we uncover a role of TOP1a in transcriptional silencing of
TEs. We exploited a luciferase-based reporter (LUCL) that
undergoes transcriptional silencing by DNA methylation [20] to
perform a chemical genetics screen. We found that camptothecin
(CPT) released the DNA methylation of LUCL and de-repressed its
expression. CPT is a well-studied natural quinoline alkaloid that
targets type 1B topoisomerases [21,22]. Both the addition of CPT
and loss-of-function in TOP1a led to the de-repression of RdDM
target loci accompanied by a release of DNA methylation and/or
a decrease in H3K9me2 levels. TOP1a is dispensable for Pol IV-
mediated siRNA biogenesis but is required for the production of
Pol V-dependent, long non-coding RNA transcripts. Consistent
with the current model that these transcripts recruit siRNA-AGO4
to chromatin, inactivation of TOP1a resulted in reduced AGO4
occupancy at these loci. Taken together, through the identification
of TOP1a as a player in RdDM, we have assigned new roles to a
protein affecting DNA topology.
Results
Camptothecin releases the silencing of LUCL
To identify genes involved in DNA methylation, we performed
a chemical genetics screen with LUCL, a transcriptionally-silenced
luciferase (LUC)-based reporter line [20]. In LUCL, LUC is driven
by a dual 35S promoter and both the 35S promoter and the LUC
coding region harbor DNA methylation [20]. The DNA
methylation at LUCL, and consequently its transcriptional silenc-
ing, is controlled by MET1, and to a lesser extent, by the RdDM
pathway [20].
Over 3,000 compounds were screened against LUCL seedlings
for their effects on LUC expression. A hit compound, camptothe-
cin (CPT) (Figure 1A), was found to release LUC silencing in a
concentration- and time-dependent manner (Figure 1B and C).
Interestingly, CPT released LUC silencing in a bi-phasic manner,
with optimal levels at 10 mM. Further, the release of LUC activity
was not observed until one day of chemical addition in a time course
assay (Figure 1B). Consistently, continuous live imaging revealed
that an increase in LUC activity occurred at about 15 hr after the
addition of the chemical (Figure 1C). The slow kinetics suggested
that cell division is likely necessary for the de-repression of the
reporter. The effects of CPT on LUC protein activity reflected a
release of LUCL silencing, as the addition of CPT led to an increase
in LUC transcript levels (Figure 1D). Consistent with the dose-
dependent effects of CPT on LUC activity, LUC transcript levels
were most de-repressed at 10 mM of CPT (Figure 1D).
Previous experiments with LUCL ruled out that it reports miRNA
activity, even though it contains the miR172 binding sequence [20].
Consistently, we found that the addition of CPT did not release the
LUC activity of a miRNA reporter line, Pro35S::LUC Pro35S::miR-
LUC (Figure 1C; [23]). Thus, CPT released the LUC activity of
LUCL through a miRNA-independent mechanism.
To determine whether CPT increased LUC transcript levels by
reducing DNA methylation, we performed McrBC-PCR to exam-
ine the methylation status of LUCL. After digestion of genomic
DNA with McrBC, an enzyme that only cuts methylated DNA
[24], 35S promoter sequences were amplified by PCR. In the
DMSO-treated control sample, little product was observed, indi-
cating that this region was highly methylated in LUCL. However,
after CPT treatment, the amount of PCR products increased
(Figure 2A), suggesting that CPT treatment led to a reduction in
35S promoter methylation. In addition, the DNA methylation
status of the 35S promoter and the LUC coding region was
examined by bisulfite sequencing (Figure 2B). The addition of
10 mM CPT resulted in a drastic reduction of CHH methylation,
and to some extent CHG methylation, in region #1 (Figure 2C).
CG methylation was largely unaffected upon CPT treatment, with
the exception of region #4 (Figure 2C).
The CPT target, TOP1a, promotes CG methylation at 5S
repeats
Due to their potent anti-cancer properties, CPT and its analogs
have been intensely studied. The cellular target of CPT is topo-
isomerase I and the mechanism by which CPT inhibits topoisom-
erase I is well understood [25]. Given this knowledge, our finding
that CPT de-represses LUCL implicated TOP1a in transcriptional
gene silencing. A top1a mutant allele, top1a-2, had been found in
an unrelated project (Xigang Liu and Xuemei Chen, unpublished
Author Summary
DNA topoisomerase is an enzyme that releases the
torsional stress in DNA generated during DNA replication
or transcription. Here, we uncovered an unexpected role of
DNA topoisomerase 1a (TOP1a) in the maintenance of
genome stability. Eukaryotic genomes are usually littered
with transposable elements (TEs) and repeats, which pose
threats to genome stability due to their tendency to move
or recombine. Mechanisms are in place to silence these
elements, such as RNA-directed DNA methylation (RdDM)
and histone H3 lysine 9 dimethylation (H3K9me2) in plants.
Two plant-specific RNA polymerases, Pol IV and Pol V,
generate small and long noncoding RNAs, respectively,
from TEs and repeats. These RNAs then recruit protein
factors to deposit DNA methylation or H3K9me2 to silence
the loci. In this study, we found that treatment of plants
with camptothecin, a TOP1a inhibitor, or loss of function in
TOP1a, led to the de-repression of RdDM target loci, which
was accompanied by loss of H3K9me2 or DNA methyla-
tion. The role of TOP1a in RdDM could be attributed to its
promotion of Pol V, but not Pol IV, transcription to
generate long noncoding RNAs.
TOP1a Promotes Transcriptional Silencing
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results). The top1a-2 mutant carried a CRT point mutation in the
second exon, which generates a premature stop codon (Figure
S1A). top1a-2, which had been isolated in the Landsberg erecta
background, was introgressed into Col-0 through five backcrosses
to derive top1a-2Col. top1a-2Col was then crossed to LUCL in the
Col-0 background. Unlike CPT, which released LUC activity, the
top1a-2Col mutation was not able to release LUC activity (Figure
S1B), probably due to activity of the partially redundant TOP1b
gene.
We next asked whether TOP1a inactivation or CPT treatment
affected DNA methylation of endogenous RdDM loci. 5S rDNA is
present with thousands of copies in the genome and is under
RdDM regulation [5]. We digested genomic DNA with HpaII, an
enzyme that cuts unmethylated DNA in a CG context, to deter-
mine the status of 5S rDNA methylation. We found that, like nrpe1-
11, a Pol V mutant, top1a-2 and CPT-treated seedlings had less
methylated DNA, as indicated by the increase in intensity of the
lower molecular weight restriction fragments (Figure 2D). top1a-7
(also known as mgo1-7 [26]; Figure S1A) has weaker developmental
defects than top1a-2Col. The top1b-1 loss-of-function mutant in the
Col-0 background (Figure S1A) has no obvious morphological
defects (Xigang Liu and Xuemei Chen, unpublished results). CG
methylation at 5S repeats was only weakly reduced in top1a-7
mutants and unaffected in top1b-1 mutants. Similarly, DNA blot
analyses were conducted to examine CHGmethylation atMEA-ISR
and 180 bp repeats (Figure S1C and D), and CHH methylation at
5S rDNA repeats. Only a slight reduction in CHG methylation at
the 180 bp repeats was detected in top1a-2 (Figure S1D). top1a-2 was
indistinguishable from the isogenic Ler parental line in terms of
CHG methylation at MEA-ISR (Figure S1C) or CHH methylation
at 5S repeats (Figure S1D).
TOP1a has a limited role in DNA methylation in the
genome
The studies above on a small number of loci revealed a limited
role of TOP1a in DNA methylation. In order to obtain a global
view of the function of TOP1a in DNA methylation, we performed
whole genome bisulfite sequencing (MethylC-seq) on Ler, top1a-2,
Col-0, top1a-7, nrpd1-3 (a Pol IV mutant) and nrpe1-11 seedlings. A
total of 10 libraries representing one to three biological replicates
of the genotypes (Table S1) were sequenced. Acceptable bisulfite
conversion efficiency (Table S1) and read coverage (Table S2)
were achieved for each library.
We identified differentially methylated regions (DMRs) using
established procedures in the literature (see Material and Methods
and Text S1). We compared each mutant to its wild-type control
in the same biological replicate. We also called DMRs among the
three Col-0 replicates to establish the background of spontaneous
DMRs in wild type. Despite the high degree of reproducibility
of the biological replicates (Table S3), when the three Col-0
Figure 1. CPT releases LUC activity of LUCL. (A) Chemical structure of CPT. (B) Time- and concentration-dependent de-repression of LUCL by CPT.
Seedlings were subjected to CPT treatment in 96-well plates and imaged for LUC activity at different time points (shown to the left of the image) after
CPT addition. D =DMSO-treated seedlings. Col-0 wild type (without the LUCL transgene) was included as a negative control. (C) Effects of CPT
treatment on various transgenes. LUC activity was measured over time using an automated luciferase reader. The x-axis indicates the time of
incubation in terms of hours:minutes after addition of 10 mM CPT or DMSO. The y-axis indicates the relative fold change of LUC activity upon
treatment of CPT as compared to DMSO. CPT affects the activity of LUCL but not Pro35S:LUC Pro35S:mir-LUC, a reporter line in which the LUC transgene
reports miRNA activity [23], Pro35S:LUC, [23], or LUCH, a reporter line in which the LUC transgene is silenced specifically by CHH methylation [36]. (D)
qRT-PCR measuring LUC transcript levels upon addition of different concentrations of CPT. Three biological replicates, each with three technical
replicates, were performed. Error bars represent standard deviation from the three biological replicates.
doi:10.1371/journal.pgen.1004446.g001
TOP1a Promotes Transcriptional Silencing
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Figure 2. Addition of CPT or loss of TOP1a releases DNAmethylation. (A) McrBC-PCR-based methylation analysis of the 35S promoter in LUCL
seedlings treated with CPT. At2g19920 is unmethylated and serves as an internal loading control. The number listed above indicates the
concentration (in mM) of CPT added. D=DMSO. (B) A schematic diagram of the LUCL transgene. The numbered black lines indicate the regions for
which bisulfite sequencing was performed (Figure 2C). (C) Levels of DNA methylation of LUCL in DMSO- and CPT-treated seedlings as determined by
bisulfite sequencing. The regions correspond to the numbered lines in Figure 2B. (D) Loss of TOP1a results in reduced 5S rDNA methylation. Genomic
DNA was digested with HpaII followed by Southern blotting. Less methylated DNA is expected to yield a higher intensity of bands lower down the
gel as in nrpe1-11 (a Pol V mutant). In the CPT-treated sample, 25 mM of CPT was used. top1a-7, top1b-1, and nrpe1-11 are to be compared to Col-0
(wild type), and top1a-2 is to be compared to Ler (wild type).
doi:10.1371/journal.pgen.1004446.g002
TOP1a Promotes Transcriptional Silencing
PLOS Genetics | www.plosgenetics.org 4 July 2014 | Volume 10 | Issue 7 | e1004446
replicates were subjected to the DMR analysis, we found
thousands of CHH DMRs, but very few CG and CHG DMRs,
between any two Col-0 replicates (Table S4A). In MethylC-seq
data of three Col-0 replicates from a published study [27], we also
identified thousands of CHH DMRs between any two replicates
(Table S4B). This suggested that CHH methylation is considerably
variable. In light of such variability, we took a conservative
approach towards the identification of robust DMRs by consid-
ering only the overlap between two biological replicates or mutant
alleles. For example, to derive DMRs between wild type and
nrpd1-3 or nrpe1-11, we first compared the mutant to wild type
within each biological replicate and then retained only DMRs that
overlapped in both biological replicates (Table S5B and C). To
derive DMRs between wild type and top1a, we first compared
top1a-7 to Col-0 and top1a-2 to Ler, and then obtained the over-
lapped DMRs between the two alleles (Table S5A). In addition,
hypervariability (HV) regions that are prone to changes in DNA
methylation over generations [28,29] were subtracted from the
overlapped DMRs. The final set of CHH DMRs between wild
type and nrpd1-3 (or nrpe1-11) consisted of over 7,500 loci showing
reduced DNA methylation in the mutants (Table S5B and C),
consistent with the known roles of Pol IV and Pol V in CHH
methylation [27,30]. The final set of DMRs between wild type and
top1a consisted of the following: reduced in methylation in top1a—
97 (CHH), 35 (CG), and 0 (CHG); and increased in methylation in
top1a — 10 (CHH), 9 (CG), and 1 (CHG) (Figure 3A, Table S5A
and Table S6). The overall change in CHH methylation in top1a
was very limited in comparison to that in nrpd1-3 or nrpe1-11
(Table S5). Most of the 97 WT-top1a CHH DMRs are in TEs or
intergenic regions (Figure 3B). 91% of the WT-top1a CHH DMRs
require Pol IV or Pol V for their CHH methylation (Figure 3C).
This suggested that TOP1a promotes DNA methylation at a small
number of RdDM loci.
TOP1a silences transposons through DNA methylation
and H3K9 dimethylation
Since the methylation-sensitive DNA blot analyses only revealed
an effect of top1a alleles on DNA methylation at the 5S and 180 bp
repeats and the methylome profiling studies did not support a
global role of TOP1a in DNA methylation, we sought to evaluate
whether TOP1a is required for the transcriptional silencing of
endogenous RdDM loci. qRT-PCR was performed to determine
transcript levels from seven well-known RdDM loci. In both wild-
type seedlings treated with CPT as well as top1a (both top1a-2 and
top1a-7) seedlings, these endogenous siRNA target loci were de-
repressed (Figure 4A). This confirmed a role of TOP1a in silencing
the RdDM target loci.
We asked whether the release of transcriptional silencing of
endogenous RdDM target loci (Figure 4A) in top1a or CPT-treated
seedlings was accompanied by a loss of DNA methylation. We
performed McrBC-qPCR assays to quantify the levels of DNA
methylation amongst different genotypes/treatments at six endog-
enous RdDM loci. At most of the loci, DNA methylation was
reduced in the two top1a mutants, but the reductions were small in
top1a-7 (Figure 4B). Treatment of wild-type (Ler) plants with CPT
resulted in reductions in DNA methylation at four of the six tested
loci (Figure S1E). Although the overall trend of reduced DNA
methylation in the two top1a mutants and CPT treated plants
agreed with the observed de-repression of these loci, there were
also inconsistencies whereby de-repression was not accompanied
by reductions in DNA methylation, such as at siR02 in top1a-2 and
CPT-treated plants.
This incomplete correlation between TE de-repression and a
reduction in DNA methylation prompted us to ask whether TOP1a
silences TEs through another mechanism. Previous studies have
shown that H3K9me2 is a major repressive mark for transposon
silencing and that H3K9me2-dependent silencing acts in concert
or in parallel with RdDM [31,32,33]. Like DNA methylation,
H3K9me2 is targeted to specific TEs through siRNA-AGO4 [7].
Thus, we investigated whether loss of TOP1a function or CPT
treatment altered H3K9me2 levels at TEs. Chromatin immuno-
precipitation (ChIP)-qPCR showed that H3K9me2 levels at AtSN1,
sir02, cluster4, AtGP1, and AtMuI were reduced in both top1a-7 and
nrpe1-11 (Figure 4C). We also performed ChIP-qPCR on LUCL
seedlings treated with DMSO or CPT. CPT treatment was found to
cause a strong reduction in H3K9me2 levels at four TE loci
(Figure 4D). As CPT was initially isolated through a chemical
genetics screen with LUCL, we asked whether the LUC transgene in
LUCL also harbored H3K9me2 and, if so, whether CPT treatment
reduced its H3K9me2 levels. Indeed, ChIP-qPCR showed that the
d35S of the LUC transgene (region #1 in Figure 2B) harbored
H3K9me2, withCPT treatment reducingH3K9me2 levels (Figure 4D).
As H3K9me2, which is introduced by KYP and its paralogs,
and CHG methylation, which is deposited by CMT3, act in a self-
reinforcing loop, and both H3K9me2 and CMT3 contribute to
CHH methylation [14,16], we asked whether the role of TOP1a in
DNA methylation depends on KYP or CMT3. To address this
question, we treated Ler (wild-type), kyp-2 and cmt3-7 plants with
CPT to inhibit topoisomerase I activity and then assayed DNA
methylation at six TE loci. CPT treatment of wild-type plants
resulted in reduced DNA methylation at four of the six loci (Figure
S1E). The reduction in DNAmethylation caused by CPT treatment
was minimal at these four loci in either cmt3-7 or kyp-2 (Figure S1E).
This suggested that the effects of TOP1a in DNA methylation
require CMT3- and KYP-mediated H3K9 dimethylation.
TOP1a does not affect small RNA levels
The promotion of DNA methylation and/or H3K9me2 depo-
sition at TEs implicates a role of TOP1a in RdDM, a process that
involves Pol IV and Pol V. As topoisomerases are required to release
DNA topological tension generated by transcription [17], it would
be reasonable to expect that TOP1a is required for the activities of
either Pol IV or Pol V. We first tested whether TOP1a is required
for the activities of Pol IV, the output of which is the accumulation
of 24-nt siRNAs from RdDM target loci. RNA blot analysis showed
that siRNA accumulation at several loci was similar in Ler and top1a-
2 (Figure S3A). To gain a global view on the potential relationship
between TOP1a and Pol IV, we compared deep sequencing profiles
of small RNAs from Ler, top1a-2, Col-0, nrpd1-3, and nrpe1-11. The
size distributions of all small RNA reads in Ler and top1a-2 were
almost identical (Figure S3B). To determine whether TOP1a affects
siRNA accumulation at specific regions of the genome, we identified
differential small RNA regions (DSRs). While large numbers of
DSRs were found in nrpd1-3 or nrpe1-11 relative to the wild-type
control, consistent with the essential role of Pol IV and the auxiliary
role of Pol V in siRNA biogenesis [3,5,6], very few were found in
top1a-2 (Table S7). Furthermore, analysis of small RNA abundance
throughout the genome did not support a global role of TOP1a in
small RNA accumulation (Figure S3C). Therefore, Pol IV activity
does not appear to require TOP1a.
Given that we had found 71 WT-top1a DSRs (Table S7), we
asked whether the reduced CHH methylation at the 97 WT-top1a
DMRs was associated with reduced siRNA levels. We found that
only 11 of the 97 DMRs overlapped with WT-top1a DSRs
(Figure 3D). A representative of such a locus is shown in Figure
S2A. Most of the 97 DMRs did not overlap with the 71 WT- top1a
DSRs; two such loci are shown in Figure S2B and C. Therefore,
the reduced CHH methylation in top1a could not be explained by
TOP1a Promotes Transcriptional Silencing
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reduced siRNA levels. On the other hand, more than 60% of the
97 WT-top1a DMRs overlapped with WT-nrpd1 DSRs (Figure 3D;
Figure S2A and B), suggesting that these regions, which require
TOP1a for CHH methylation, undergo Pol IV-dependent siRNA
production. Therefore, TOP1a must promote CHH methylation
at these RdDM loci independently of siRNA biogenesis.
TOP1a promotes the production of Pol V-dependent
transcripts and AGO4 occupancy at TEs
We next tested whether TOP1a promotes the production of Pol
V-dependent transcripts. We performed qRT-PCR and RT-PCR
to detect Pol V-dependent transcripts from eight loci, MEA-ISR,
AtSN1, and six IGN loci that produce such transcripts [9,30]. At all
eight loci, the levels of the Pol V-dependent transcripts were
reduced in top1a-2 as compared to Ler (Figure 5A and B). We
previously showed that Pol II generates long noncoding transcripts
at the soloLTR locus [34]. The accumulation of these transcripts at
soloLTR was also reduced in top1a-2 (Figure 5B). Therefore,
TOP1a contributes to the production of Pol V-dependent or Pol
II-dependent long noncoding transcripts.
As the Pol V- or Pol II-dependent long noncoding transcripts
facilitate the recruitment of siRNA-AGO4 to chromatin to ultimately
result in RdDM or H3K9me2 deposition, we asked whether TOP1a
promotes AGO4 occupancy at these RdDM target loci. ChIP-
qPCR was conducted with anti-Myc antibodies in Myc-AGO4 [35]
and Myc-AGO4 top1a-2 plants. At four well-known RdDM target
loci, AGO4 occupancy was reduced in top1a-2 (Figure 5C).
To determine whether TOP1a might act directly at these
RdDM loci, we examined TOP1a occupancy at these loci. We
first generated a TOP1a-HA fusion driven by the TOP1a promoter
(TOP1a-HA) and introduced it into top1a-2. The morphological
phenotypes of top1a-2 plants were completely rescued by TOP1a-
HA, indicating that the transgene was functional. We then per-
formed ChIP-qPCR using anti-HA antibodies. TOP1a was found
at all six loci examined (Figure 5D).
Discussion
Beginning with a forward chemical genetics screen with a trans-
criptionally silenced reporter, LUCL, we have discovered that the
well-studied anti-cancer compound CPT can de-repress loci under-
going transcriptional silencing by releasing H3K9 methylation and/
or DNA methylation. As topoisomerase I is the cellular target of
CPT, this implicates topoisomerase I in transcriptional silencing.
Indeed, two top1a alleles, top1a-2 and top1a-7, mimic CPT treatment
in de-repressing the expression of endogenous RdDM target loci
and reducing H3K9me2 or DNA methylation levels at these loci.
Figure 3. TOP1a does not globally impact DNA methylation but promotes CHH methylation at a small number of loci. (A) Pie charts
showing that the great majority of WT- top1a DMRs show reduced DNA methylation in top1a. Each circle represents total WT- top1a DMRs in a
methylation context (CG or CHH). The red and blue areas represent DMRs with reduced and increased DNA methylation in top1a, respectively. The
numbers indicate the numbers of DMRs in each category. The numbers in the parentheses represent the percentage of the DMR category in total
DMRs. (B) The majority of WT- top1a CHH DMRs showing reduced DNA methylation in top1a overlap with TEs (74%, blue). Those that overlap with
genes and intergenic regions are shown in red (7%) and green (19%), respectively. (C) The majority of WT- top1a CHH DMRs overlap with CHH DMRs
between WT and nrpd1 or WT and nrpe1 (91%, red), suggesting that these regions require Pol IV or Pol V for CHH methylation. The portion of WT-
top1a CHH DMRs not overlapping with WT-nrpd1 or WT-nrpe1 CHH DMRs are shown in blue (9%). (D) Overlap between WT- top1a CHH DMRs with
DSRs (differential small RNA regions) between WT and nrpd1 or WT and top1a. There is little overlap between WT-top1a CHH DMRs and WT-top1a
DSRs.
doi:10.1371/journal.pgen.1004446.g003
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Here, we first consider whether TOP1a acts through RdDM or
independently of RdDM to silence TEs. RdDM requires Pol IV
and Pol V, which generate siRNAs and long noncoding RNAs,
respectively. We show that TOP1a is dispensable for siRNA
accumulation, but is required for the production of Pol V-
dependent long noncoding RNAs, which are known to recruit
siRNA-AGO4 to chromatin. Consistently, TOP1a promotes the
recruitment of AGO4 to RdDM target loci. Moreover, 88 out of
97 WT-top1a CHH DMRs with reduced methylation in top1a also
require Pol IV or Pol V for CHH methylation (Figure 3C). 5S
rDNA loci lose CG methylation in top1a-2 and nrpe1-11 mutants,
and provide an example of a genomic region where CG
methylation requires TOP1a, Pol IV, and Pol V. These data
suggest that TOP1a acts at least in part through RdDM to silence
TEs and repeats. However, MethylC-seq analyses revealed that
TOP1a has a limited role in DNA methylation. We envision two
possibilities for the limited role in DNA methylation observed for
TOP1a. First, TOP1a may have a much broader role in DNA
methylation in the genome, and the limited effects of top1a
mutants on DNA methylation could be due to the redundant
functions of TOP1b. So far, our efforts to knock down TOP1b in
the top1a-2 background have been unsuccessful. Second, TOP1a’s
primary functions may lie in the promotion of H3K9 dimethyla-
tion, with DNA methylation being a secondary effect of H3K9
dimethylation. From our studies of a limited number of RdDM
loci, we found that reduced H3K9me2 levels, but not necessarily
reduced DNA methylation, always accompany the de-repression
of these loci by CPT treatment or by mutations in TOP1a.
Therefore, it is likely that the primary function of TOP1a lies in
facilitating H3K9me2 deposition. Consistent with this model, the
observed effects of CPT treatment on DNA methylation at four
loci require CMT3 and KYP, both of which promote H3K9
dimethylation. Another observation consistent with this hypothesis
is that CPT treatment had no effect on LUCH (Figure 1C), a
reporter gene that is strictly repressed by CHH methylation and is
insensitive to loss of function in CMT3 [36]. As CMT3-mediated
DNA methylation requires H3K9me2 [14], we presume that
LUCH is not repressed by H3K9me2. The lack of an effect of CPT
treatment on LUCH would be consistent with TOP1a acting in
TGS through H3K9me2 deposition.
Our finding that TOP1a promotes the production of Pol V-
dependent transcripts is consistent with what is known about the
function of topoisomerases in bacteria and yeast. Topoisomerases are
thought to facilitate transcription elongation by relaxing supercoils
[37]. Consistent with this model, loss of Top1 in Schizosaccharomyces
pombe results in the accumulation of Pol II in gene bodies [38,39]. The
parallels of Pol V- and Pol II-mediated transcription have recently been
highlighted [40], and we propose that TOP1a promotes transcription
elongation by Pol V as it does for Pol II.
Although we prefer a model in which TOP1a acts in RdDM by
facilitating the production of long noncoding RNAs by Pol V or
Pol II, an alternative model cannot be overlooked. Studies in other
systems have shown that topoisomerases interact with SMC-
containing proteins acting in chromosome compaction [41,42].
DMS3, a player of the RdDM machinery, contains an SMC
domain [43]; therefore, there is a possibility that TOP1a may
facilitate RdDM through DMS3.
In summary, we have discovered a role for DNA topoisomerase
I in H3K9 methylation and DNA methylation in Arabidopsis.
Another study showed that chemical inhibitors of topoisomerases I
and II release the epigenetic silencing of an imprinted gene in mouse
[44]. Together, these studies point to a role of topoisomerases in
epigenetic silencing. Given that CPT is a canonical anti-cancer
compound and several of its derivatives are presently used in cancer
Figure 4. TOP1a promotes transposon silencing at endogenous
RdDM target loci through H3K9me2 deposition. In (A) to (D),
error bars represent standard deviation calculated from three biological
replicates, each with three technical replicates. In (A) and (B), top1a-7,
top1a-2 and CPT-treated LUCL were compared to Col-0, Ler, and DMSO-
treated LUCL respectively. The relative levels to these controls (set to
1.0) are shown. The loci tested are labeled on the x axis. (A) Loss of
TOP1a or addition of CPT results in RdDM target loci de-repression. (B)
Loss of TOP1a or addition of CPT results in a release of DNA methylation
at some loci. McrBC-qPCR analysis was performed to quantify DNA
methylation levels in top1a or CPT-treated plants. Higher DNA levels in
this assay correlate with lower levels of DNA methylation. At1g40129
served as an internal unmethylated control. (C) Loss of TOP1a results in
reduced H3K9me2 levels at endogenous RdDM loci. ChIP-qPCR was
performed to measure H3K9me2 levels at five RdDM target loci. eIF4A1,
which does not harbor H3K9me2, was used as an internal control. 2
= samples processed without antibody. += samples processed with anti-
H3K9me2 antibodies. (D) CPT treatment results in reduced H3K9me2
levels at the LUCL transgene and four endogenous RdDM loci. LUCL
plants were treated with either DMSO or 10 mM CPT and subjected to
ChIP. qPCR was performed with the immunoprecipitated DNA for the
LUCL transgene and four endogenous RdDM loci. eIF4A1 was used as an
internal negative control. 2= samples processed without antibody. +
= samples processed with anti-H3K9me2 antibodies.
doi:10.1371/journal.pgen.1004446.g004
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therapy [25], the emerging role of topoisomerase I in epigenetic
gene silencing allude to the mode of carcinogenesis.
Materials and Methods
MethylC-seq analysis: Identification of Differentially
Methylated Regions (DMRs)
Raw data from Illumina sequencing were filtered to remove
reads that failed to pass the Illumina quality control and to
condense multi-copy reads to a single copy. Hereafter, the reads
were mapped to TAIR 10 Arabidopsis genome as well as a C-to-T
converted genome using BS_Seeker [45] with default settings.
Only perfectly and uniquely mapped reads were retained. For Ler
and top1a, which are in the Landsberg ecotype, the reads were
mapped to a pseudo-Ler genome generated by incorporating the
Ler polymorphisms into the Tair10 Columbia genome (ftp://
ftp.arabidopsis.org/Polymorphisms/Ecker_ler.homozygous_snp.txt).
This enables the direct comparison of DMR regions between the
Columbia and Landsberg samples.
DMRs were identified following a published method [27] with
some modifications. In brief, the genome was split into continuous
100 bp windows. The Cs or Ts were counted in each window in
the three different contexts (CG, CHG or CHH) separately. Only
windows with least 4 Cs each sequenced at least 4 times in the
wild-type sample were kept for the DMR analysis. The
methylation level for a window was determined as:
methylation level~
X
aiX
aizbið Þ
in which ai denotes the number of read ‘‘C’’s and bi denotes the
number of read ‘‘T’’s mapping to the ith cytosine site. The
methylation level in each window in wild type is then compared to
the corresponding window in a mutant. A methylation difference
of 0.4, 0.2, and 0.1 for CG, CHG, and CHH, and an adjusted p-
value (FDR),0.01 (Fisher’s exact test) were used as the cutoff for
defining DMRs.
Additional measures were taken to reduce experimental noise.
First, two or three biological replicates/alleles were examined. In
deriving initial DMRs, we compared each wild type/mutant pair
from the same biological replicate (Table S5). Then, DMRs
located within 200 bp of each other were merged. Next, the
overlap in DMRs from the two biological replicates/alleles was
identified (Table S5). Finally, we removed the DMRs that
overlapped with the hypervariability (HV) regions found to be
prone to changes in DNA methylation [28,29] (Table S5).
See Text S1 for Supplemental Methods and Table S8 for oli-
gonucleotides used in this study.
Accession numbers and data deposition
The gene accession numbers used in this study are At5g55310
(TOP1a), At5g55300 (TOP1b), At1g05460 (NRPD1), and At2g40030
Figure 5. TOP1a promotes the production of Pol V-dependent
transcripts and AGO4 occupancy at RdDM loci. (A) TOP1a
contributes to the production of Pol V-dependent transcripts at MEA-
ISR. qRT-PCR was performed to quantify Pol V-dependent transcripts at
MEA-ISR. The Pol V mutant nrpe1-11 was included as a control. nrpe1-11
and top1a-2 should be compared to the wild-type strains Col-0 and Ler,
respectively. Error bars represent standard deviation calculated from
three technical replicates. (B) TOP1a contributes to the production of
Pol II- or Pol V-dependent transcripts at many loci (noted on the left of
the gel images). RT-PCR was performed to detect Pol II-dependent
transcripts at soloLTR and Pol V-dependent transcripts at the other
seven loci (AtSN1 and six IGN loci). When multiple bands are present,
the band representing the Pol V-dependent transcript is indicated by an
arrow. Actin (ACT) served as an internal loading control for all the gels
above. nrpe1-11 was included as a control. nrpe1-11 and top1a-2 should
be compared to the wild-type strains Col-0 and Ler, respectively. –RT is
the negative control in which reverse transcription was conducted in
the absence of reverse transcriptase. Three biological replicates were
performed and one representative image is shown. (C) Loss of TOP1a
results in a decrease in AGO4 occupancy. Ten-day old wild-type and
top1a-2 seedlings, both of which contain a Myc-AGO4 transgene, were
subjected to ChIP with anti-MYC antibodies. qPCR was then performed
on the immunoprecipitated DNA for four endogenous RdDM loci. ‘‘2’’
and ‘‘+’’ signs represent ‘‘no antibody’’ or ‘‘anti-Myc antibodies’’,
respectively. Error bars represent standard deviation calculated from
three biological replicates. (D) TOP1a is present at six RdDM loci. Ten-
day old Ler (used as a negative control) and TOP1A-HA top1a-2
seedlings were subjected to ChIP with anti-HA antibodies. qPCR was
then performed on the immunoprecipitated DNA for six endogenous
RdDM loci. ‘‘2’’ and ‘‘+’’ signs represent ‘‘no antibody’’ or ‘‘anti-HA
antibodies’’, respectively. Error bars represent standard deviation
calculated from three technical replicates. Two biological replicates were
performed and showed the same trend. One biological replicate is shown.
doi:10.1371/journal.pgen.1004446.g005
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(NRPE1). MethylC-seq and small RNA-seq read data have been
deposited into NCBI GEO under the identification numbers
GSE50691 and GSE50720, respectively.
Supporting Information
Figure S1 The nature of top1a and top1b alleles and the effects of
top1a-2 on DNA methylation at several loci. (A) Schematic
representation of TOP1a and TOP1b and several mutant alleles.
The white triangles represent T-DNA insertions. top1a-2 is a point
mutation that causes an early stop codon (star). (B) top1a-2Col does
not de-repress LUCL. top1a-2Col is top1a-2 introgressed into Col-0
through five backcrosses. LUCL ago4-6 and LUCL drm2-6 were
included as positive controls, as ago4-6 and drm2-6 weakly de-
repress LUCL [20]. (C) DNA blot analysis of the MEA-ISR locus.
Genomic DNA from ten-day old seedlings was digested with MspI
and hybridized with a probe corresponding to the MEA-ISR locus.
MspI cuts unmethylated DNA in a CHG context. The upper and
lower bands represent methylated and unmethylated DNA. nrpe1-
11 is a Pol V mutant in the Col-0 background. No change was
observed between top1a-2 and Ler (the wild-type control for top1a-
2). (D) DNA blot analysis of 180 bp and 5S repeats. Left panel:
Genomic DNA from ten-day old seedlings was digested with MspI
and hybridized with a probe corresponding to the 180 bp cen-
tromeric repeats. cmt3-7 is a control with reduced CHG methy-
lation. top1a-2 has a slight reduction in CHG methylation at the
180 bp repeats as compared to Ler. Right panel: Genomic DNA
from ten-day old seedlings digested with HaeIII and hybridized
with a probe corresponding to the 5S loci. HaeIII recognizes the
GGCC sequence, but cannot cut when the last C is methylated,
thus it is sensitive to CHH methylation. nrpd1-3 is a Pol IV mutant
and nrpe1-11 is a Pol V mutant. Both serve as controls with reduced
CHHmethylation and are to be compared to Col-0 as wild type. No
change was observed between top1a-2 and Ler, the wild-type control
for top1a-2. (E) CPT treatment results in reductions in DNA
methylation at several RdDM loci in a CMT3- and KYP-dependent
manner. McrBC-qPCR analysis was performed to quantify DNA
methylation levels in CPT-treated Ler (wild type), cmt3-7 or kyp-2
ten-week-old seedlings. Relative DNA ratios between CPT treat-
ment and DMSO treatment are shown. Higher DNA levels in this
assay correlate with lower levels of DNA methylation. At1g40129
served as an internal unmethylated control. Error bars represent
standard deviations calculated from three biological replicates.
(TIF)
Figure S2 Representative screen shots of an overlay of MethylC-
seq and small RNA-seq at three genomic regions in various
genotypes. The three different loci (A–C) are indicated by their
genomic coordinates above the tracks. The top five tracks depict
CHH methylation (blue vertical lines). The y-axis indicates the
methylation level from 0 (0%) to 1 (100%). The next four tracks
represent small RNAs (purple vertical lines). The y-axis indicates
small RNA abundance normalized by read depth. The positions of
genes or transposable elements (TEs) are indicated below the small
RNA tracks, with the green and brown rectangles representing
genes and TEs, respectively. The position of these boxes (above or
below the line) indicates which DNA strand those features are
transcribed from. The black, orange, and purple rectangles at the
bottom indicate the positions of WT-top1a DMRs, Col-nrpd1-3
DSRs, and Ler-top1a-2 DSRs, respectively. DMRs, differentially
methylated regions; DSRs, differential small RNA regions.
(TIF)
Figure S3 TOP1a does not globally contribute to small RNA
accumulation. (A) Loss of TOP1a did not significantly change siRNA
(cluster4, soloLTR, siR1003) and miRNA (miR173) levels. RNA
blots were performed for Ler (wild type) and top1a-2. U6 was used as
an internal loading control. The numbers indicate the relative
abundance of the small RNAs in the mutant (with that in the wild
type set to 1.0). (B) The size distribution of total small RNA reads in Ler
and top1a-2 is largely similar. (C) Box-and-whisker plots of global small
RNA abundance in various genotypes. The whiskers extend to themost
extreme data points that are no more than 1.5 times the interquartile
range from the box. Significant reduction is indicated by ‘‘*’’ (P,10210
Mann–Whitney U test). nrpd1-3 and nrpe1-11 have mutations in Pol IV
and Pol V, respectively, and are to be compared to Col-0 (wild type).
Small RNAs were mapped to the genome, which is divided into
500 bp static windows. Only windows in which read abundance was
at least 10 RPM in Col-0 or Ler are considered. The x-axis rep-
resents the genotypes as indicated. The y-axis shows normalized
read abundance (in RPM, reads per million) in 500 bp windows.
Small RNA levels were unaffected in the top1amutant, whereas they
were reduced in nrpd1-3 and nrpe1-11 as compared to Col-0.
(TIF)
Table S1 Summary of bisulfite conversion efficiency for each
genotype.
(PDF)
Table S2 Read coverage of whole genome bisulfite sequencing
libraries.
(PDF)
Table S3 Correlation coefficient values for the different
biological replicates of each genotype in MethylC-seq.
(PDF)
Table S4 DMRs between wild-type samples.
(PDF)
Table S5 Derivation of DMRs between wild type and top1a,
nrpd1-3, or nrpe1-11.
(PDF)
Table S6 Final WT-top1a DMRs.
(PDF)
Table S7 Only a small number of differential small RNA regions
(DSRs) were found between wild type and top1a-2. Whole genome
high throughput sequencing was performed for small RNAs in wild
type (Col-0 and Ler), nrpd1-3, a Pol IV mutant, nrpe1-11, a Pol V
mutant, and top1a-2. nrpd1-3 and nrpe1-11 are to be compared to Col-
0 and top1a-2 is to be compared to Ler. The genome was divided into
500 bp static windows and small RNA reads in each window were
counted and compared between each mutant and its corresponding
wild type. Thousands of DSRs were found in nrpd1-3 or nrpe1-11 as
compared to Col-0, but only 71 were found in top1a-2 relative to Ler
(see Experimental Procedures for the derivation of DSRs). The
numbers of DSRs mapping to different genomic features (TE, gene,
and inergenic region) are listed. TE= transposable element.
‘‘Reduced’’ and ‘‘increased’’ refer to DSRs with reduced and
increased small RNA read counts in the mutants, respectively.
(PDF)
Table S8 Oligonucleotides used in this study.
(PDF)
Text S1 Supplemental methods.
(DOCX)
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